ドイツでのSIRT療法に最適なクリニックと費用をご発見ください2026

Selective Internal Radiation Therapy (SIRT) in Germany treats primary liver cancer and secondary liver metastases. Specialists use it for hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, and spreading colorectal cancer. This targeted radioembolization concentrates yttrium-90 microspheres directly within hepatic arteries to destroy localized tumor cells.

• Primary liver cancers: Effectively treats hepatocellular carcinoma and intrahepatic bile duct tumors.
• Colorectal metastases: Managed when liver-dominant spreading occurs and surgery is not feasible.
• Neuroendocrine tumors: Controls liver-involved neuroendocrine malignancies as part of long-term therapy.
• Other secondary cancers: Includes liver metastases from breast cancer, uveal melanoma, and pancreatic cancer.

Bookimed Expert Insight: German university hospitals often use SIRT for downstaging tumors to make patients eligible for transplants. Clinics like Charité Berlin and Nordwest Clinic Frankfurt am Main handle high volumes, often seeing over 60,000 patients annually. This massive case volume allows specialized tumor boards to precisely determine if SIRT or chemotherapy offers better survival for liver-dominant cases.

Patient Consensus: Patients often seek SIRT when standard surgery or ablation is no longer an option. It is frequently requested specifically for colorectal or neuroendocrine metastases to control liver-dominant disease growth.

SIRT therapy eligibility requires patients to have inoperable primary liver cancer or metastatic tumors spread to the liver from other organs. Candidates must maintain compensated liver function and a liver-dominant disease profile where the cancer has not significantly spread to other body systems.

• Tumor types: Includes hepatocellular carcinoma, cholangiocarcinoma, or metastatic colorectal, breast, and neuroendocrine cancers.
• Liver function: Requires Child-Pugh Class A status to ensure the liver can withstand radiation.
• Disease profile: Cancer must be confined to the liver or primarily located within it.
• Performance status: Patients must be physically active with an ECOG score of 0 or 1.

Bookimed Expert Insight: German oncology centers like Charité Berlin and Medical Center Solingen rely on multidisciplinary tumor boards to approve SIRT. Eligibility often hinges on the MAA scan results, which check for lung shunting. High lung shunting disqualifies patients even if their cancer type matches, making this mapping phase the most critical step in the German protocol.

Patient Consensus: Patients often find that while they meet the initial medical criteria, the final decision rests on the complex anatomy of their liver blood supply. It is common for the procedure to be ruled out late in the process due to safety concerns identified during vascular mapping.

Selective Internal Radiation Therapy (SIRT) contraindications in Germany primarily involve compromised liver function, unsuitable vascular anatomy, or excessive extrahepatic disease. Medical teams at German Cancer Society-accredited centers exclude patients with severe cirrhosis, high bilirubin levels, or significant shunting of radiation to the lungs or gastrointestinal tract during pre-treatment mapping.

• Liver function: Treatment is denied if bilirubin levels or cirrhosis severity indicate advanced liver failure.
• Vascular anatomy: Mapping must confirm radiation cannot reach the stomach, pancreas, or intestines safely.
• Disease spread: Extensive cancer outside the liver may prioritize systemic chemotherapy over localized SIRT.
• General health: Poor performance status, rapid weight loss, or active infections disqualify many candidates.

Bookimed Expert Insight: German university hospitals like Charite or Solingen use mapping angiograms to catch vascular issues early. Even if initial anatomy looks complex, specialists often perform preventative embolization to protect nearby organs. This allows some patients previously considered ineligible to safely proceed with the procedure.

Patient Consensus: Many patients find the mapping angiogram is the most stressful step. It determines if their liver can handle radiation without damaging the stomach or lungs.

Selective Internal Radiation Therapy (SIRT) is safe when performed by interventional radiologists in certified German medical institutions. Severe complications usually occur if microspheres migrate to the stomach, lungs, or healthy liver tissue. Pre-treatment mapping reduces these risks by sealing off vessels and calculating lung shunting.

• Gastrointestinal ulcers: Inadvertent microsphere reflux can cause severe stomach or duodenal ulcerations and bleeding.
• Radiation pneumonitis: Significant lung shunting causes inflammation, presenting as persistent dry cough or breathing difficulties.
• Radiation-induced liver disease: Overexposure to healthy tissue may lead to jaundice, ascites, or liver failure.
• Biliary complications: Severe inflammation of the gallbladder or bile duct injury can require surgical intervention.

Bookimed Expert Insight: German university hospitals like Charite and certified centers like Medical Center in Solingen emphasize two-stage planning. Data shows that the mandatory pre-treatment mapping scan is the most critical safety factor. Clinics with German Cancer Society accreditation often achieve higher safety by using advanced software to pinpoint precise dosing and vessel occlusion.

Patient Consensus: Patients emphasize that pre-treatment mapping is as vital as the therapy. Many report being most concerned about sudden jaundice or severe fatigue appearing weeks after the procedure.

SIRT is a minimally invasive catheter-based procedure that delivers radioactive microspheres directly to liver tumors via the hepatic artery. Interventional radiologists perform this targeted treatment in two stages, including a mapping phase and a radiation delivery phase, using real-time X-ray guidance and nuclear medicine imaging.

• Mapping phase: Radiologists use angiograms to visualize vessels and block non-target branches 1–2 weeks before treatment.
• Safety testing: Doctors inject technetium-99m test beads to check for potential shunting to the lungs.
• Microsphere infusion: Surgeons deliver millions of yttrium-90 or holmium-166 beads directly into tumor blood supplies.
• Radiation delivery: Permanent beads emit short-range beta radiation, destroying cancer cells while sparing healthy tissue.

Bookimed Expert Insight: German university hospitals like Charite or Nordwest prioritize a protocol-driven approach by strictly separating mapping and treatment by 7–14 days. While some global centers attempt faster timelines, this gap allows German specialists to meticulously coil secondary arteries, significantly reducing the risk of radiation reaching the stomach or gallbladder.

Patient Consensus: The catheter procedure is often shorter than expected, but recovery typically involves flu-like symptoms and fatigue for several days. Patients emphasize the importance of confirming whether the clinic bundles all-inclusive imaging and follow-up scans into the initial treatment plan.

Selective Internal Radiation Therapy (SIRT) is rarely a standalone cure. It serves as a palliative treatment to shrink tumors or slow disease progression. A complete cure usually requires surgical resection or a liver transplant after SIRT successfully downsizes inoperable tumors to a manageable size.

• Tumor downsizing: It shrinks large tumors to make surgical resection or transplantation possible.
• Bridging therapy: This procedure prevents tumor growth while patients wait for a donor liver.
• Hypertrophy stimulation: SIRT helps healthy liver tissue grow before surgeons remove cancerous sections.
• Precision delivery: Microspheres deliver localized radiation directly to tumors through the hepatic artery.

Bookimed Expert Insight: German oncology centers like Nordwest Clinic or Solingen often use SIRT as conversion therapy. Data shows Germany is a top-ranked destination for complex oncology because these facilities integrate SIRT with targeted therapies. This combined approach successfully transitions patients from inoperable status to candidates for curative surgery.

Patient Consensus: Patients emphasize that SIRT offers better disease control with fewer side effects than traditional chemotherapy. Most view it as a critical bridge that buys time for surgery when the cancer remains liver-limited.

Patients undergoing SIRT therapy in Germany typically require a 1-night hospital stay for observation. While the German national average for general inpatient care is 7.2 days, SIRT is a specialized arterial radiation procedure that usually allows for discharge the next morning once radiation-safety protocols are met.

• Admission duration: Most specialized centers limit hospitalization to 1 night for stable patients.
• Radiation safety: Discharge timing depends on localized radiation-safety routines and initial monitoring results.
• Observation focus: Hospitalization ensures immediate management of potential side effects like pain or nausea.
• Clinical certifications: Top facilities often hold German Cancer Society or TÜV certifications for oncology.

Bookimed Expert Insight: While SIRT is efficient, the mapping angiography and the actual treatment often occur separately. Clinics like Medical Center in Solingen or Nordwest Clinic manage high volumes, but you should verify if they require two separate admissions. Some centers bundle these into a single 2-day stay to minimize travel for international patients.

Patient Consensus: Most patients find the 1-night stay sufficient but emphasize checking post-treatment radiation precautions. They suggest confirming whether the mapping procedure requires its own dedicated overnight observation before the treatment day.